These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38848179)

  • 21. Association between cognitive impairment and gait disturbance in patients with idiopathic normal pressure hydrocephalus.
    Miyoshi N; Kazui H; Ogino A; Ishikawa M; Miyake H; Tokunaga H; Ikejiri Y; Takeda M
    Dement Geriatr Cogn Disord; 2005; 20(2-3):71-6. PubMed ID: 15908748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer's disease from healthy individuals.
    Müller S; Herde L; Preische O; Zeller A; Heymann P; Robens S; Elbing U; Laske C
    Sci Rep; 2019 Mar; 9(1):3543. PubMed ID: 30837580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
    Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
    Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychological Assessment in the Differential Diagnosis of Idiopathic Normal Pressure Hydrocephalus. An Important Tool for the Maintenance and Restoration of Neuronal and Neuropsychological Functions.
    Sindorio C; Abbritti RV; Raffa G; Priola SM; Germanò A; Visocchi M; Quattropani MC
    Acta Neurochir Suppl; 2017; 124():283-288. PubMed ID: 28120085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting Cognitive Improvement in Normal Pressure Hydrocephalus Patients Using Preoperative Neuropsychological Testing and Cerebrospinal Fluid Biomarkers.
    McGovern RA; Nelp TB; Kelly KM; Chan AK; Mazzoni P; Sheth SA; Honig LS; Teich AF; McKhann GM
    Neurosurgery; 2019 Oct; 85(4):E662-E669. PubMed ID: 30937451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Alzheimer's Disease-Associated Risk Loci on Amyloid-β Accumulation in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.
    Laiterä T; Paananen J; Helisalmi S; Sarajärvi T; Huovinen J; Laitinen M; Rauramaa T; Alafuzoff I; Remes AM; Soininen H; Haapasalo A; Jääskeläinen JE; Leinonen V; Hiltunen M
    J Alzheimers Dis; 2017; 55(3):995-1003. PubMed ID: 27802227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients.
    Lukkarinen H; Jeppsson A; Wikkelsö C; Blennow K; Zetterberg H; Constantinescu R; Remes AM; Herukka SK; Hiltunen M; Rauramaa T; Nägga K; Leinonen V; Tullberg M
    Fluids Barriers CNS; 2022 Feb; 19(1):11. PubMed ID: 35123528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
    Jeppsson A; Wikkelsö C; Blennow K; Zetterberg H; Constantinescu R; Remes AM; Herukka SK; Rauramaa T; Nagga K; Leinonen V; Tullberg M
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1117-1123. PubMed ID: 31167811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus.
    Nakajima M; Miyajima M; Ogino I; Akiba C; Kawamura K; Kamohara C; Fusegi K; Harada Y; Hara T; Sugano H; Tange Y; Karagiozov K; Kasuga K; Ikeuchi T; Tokuda T; Arai H
    J Alzheimers Dis; 2018; 66(1):319-331. PubMed ID: 30248058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral blood flow and Alzheimer's disease-related biomarkers in cerebrospinal fluid in idiopathic normal pressure hydrocephalus.
    Azuma S; Kazui H; Kanemoto H; Suzuki Y; Sato S; Suehiro T; Matsumoto T; Yoshiyama K; Kishima H; Shimosegawa E; Tanaka T; Ikeda M
    Psychogeriatrics; 2019 Nov; 19(6):527-538. PubMed ID: 30916850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
    Chen Z; Liu C; Zhang J; Relkin N; Xing Y; Li Y
    Fluids Barriers CNS; 2017 May; 14(1):13. PubMed ID: 28486988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [11C]PIB PET Is Associated with the Brain Biopsy Amyloid-β Load in Subjects Examined for Normal Pressure Hydrocephalus.
    Rinne JO; Suotunen T; Rummukainen J; Herukka SK; Nerg O; Koivisto AM; Rauramaa T; Någren K; Hiltunen M; Alafuzoff I; Rinne J; Jääskeläinen JE; Soininen H; Leinonen V
    J Alzheimers Dis; 2019; 67(4):1343-1351. PubMed ID: 30689567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline neuropsychological profile and cognitive response to cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus.
    Thomas G; McGirt MJ; Woodworth G; Heidler J; Rigamonti D; Hillis AE; Williams MA
    Dement Geriatr Cogn Disord; 2005; 20(2-3):163-8. PubMed ID: 16020945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study.
    Abu-Rumeileh S; Giannini G; Polischi B; Albini-Riccioli L; Milletti D; Oppi F; Stanzani-Maserati M; Capellari S; Mantovani P; Palandri G; Cortelli P; Cevoli S; Parchi P
    J Alzheimers Dis; 2019; 68(2):723-733. PubMed ID: 30883350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological assessments and cognitive profile mostly associated with shunt surgery in idiopathic normal pressure hydrocephalus patients: diagnostic and predictive parameters and practical implications.
    Nimni M; Weiss P; Cohen C; Laviv Y
    Acta Neurochir (Wien); 2021 Dec; 163(12):3373-3386. PubMed ID: 34480204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H; Addneuromed Consortium
    J Alzheimers Dis; 2010; 22(4):1089-97. PubMed ID: 20930314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease?
    Camargo CHF; Bronzini A; Tolentino ES; Medyk C; Schultz-Pereira GL
    Arq Neuropsiquiatr; 2018 Mar; 76(3):145-149. PubMed ID: 29809231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias.
    Said HM; Kaya D; Yavuz I; Dost FS; Altun ZS; Isik AT
    Clin Interv Aging; 2022; 17():467-477. PubMed ID: 35431542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.